
Himalayan Shilajit and Pain Relief: An Exploratory Clinical Study
Researchers evaluated the analgesic efficacy of native Himalayan shilajit as a complementary therapy in patients with myofascial pain syndrome. The study involved a group of 30 participants who received shilajit in addition to standard treatment. After 4 weeks, a significant reduction in pain intensity was observed, with 70% of participants reporting relief. Shilajit, rich in fulvic acids and minerals, may act on modulating inflammation and improving blood circulation, important factors in myofascial pain. Although the results are promising, the study has limitations, such as the small number of participants and the lack of a control group. Further research is needed to confirm these findings and understand the mechanisms involved.
